Companies / Dextera Biosciences
Dextera Biosciences
Company
Dextera Biosciences is pioneering a new class of therapeutics—dexabodies—built entirely from D-amino acids to overcome the key limitations of existing drug modalities
Dextera Biosciences has 1 investor on file, among them BEVC. Its site was last checked 19 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from BEVC
10 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (70%), Climate & Energy (20%), Industrial & Manufacturing (10%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Dextera Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BEVC adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/dexterabio.com/investors
# also
GET /v1/companies/dexterabio.com
GET /v1/companies/dexterabio.com/news